Sinovac enters partnership to begin Omicron-specific Covid-19 booster trial
The trial will enrol 300 subjects to assess the safety and immunogenicity of Sinovac's booster vaccine.
Macro
Latest in
Macro
Fauci: long Covid-19 trial endpoints ‘absolutely have to be standardised’
Clinical Trials Arena asks Dr Anthony Fauci about the biggest challenges to selecting long Covid-19 trial endpoints during a National…
By
EnGeneIC’s Covid-19 vaccine offers protection against variants in trials
Increased neutralising antibody levels against all variants, including Omicron BA2, and memory response were observed in subjects.
Overcoming obstacles in trans and nonbinary participation in clinical trials
The clinical trials sector can make small changes to make transgender, nonbinary individuals feel safe to join studies.
By
Sanofi, GSK announce positive Covid-19 vaccine trial data
Stage two of the Phase III Covid-19 vaccine trial enrolled more than 13,000 subjects aged 18 years and older.
SAVRpak Launches Moisture Control Technology to Increase Shelf-Life of Fresh Produce
Concept: US-based startup SAVRpak has introduced SAVRpak Drop-In, a moisture control technology that claims to triple the shelf life and…
Pfizer, BioNTech report positive Omicron-adapted Covid-19 vaccine data
For the monovalent 30µg and 60µg vaccines, the GMRs were 2.23 and 3.15, respectively.
CIHR awards grant for COVID-19 Network of Clinical Trials Networks
The network will progress to support critical research capacity among a national network of over 60 sites with the funding.